News & Press
Follow our news to learn how Dermagnostix is redefining molecular diagnostics in dermatology with our point-of-need microfluidics platform.
DX featured at Kompass Dermatologie
Dermagnostix is featured in the journal series ‘Karger Kompass’ aimed at clinicians and specialists in private practice with a focus on young, committed physicians with four specialist target groups of pneumologists, dermatologists, oncologists and ophthalmologists.
Freiburg-based start-up has developed a diagnostic test for neurodermatitis (Badische Zeitung)
Many people suffer from inflammatory skin diseases such as psoriasis or eczema like atopic dermatitis – but it’s often not clear exactly what the cause is: conventional methods are not always conclusive.
Subscribe to our newsletter
Dermagnostix is a young medtech company redefining molecular diagnostics in dermatology based on a cutting-edge point-of-need microfluidics platform. Our goal is to help patients around the globe get accurate, timely diagnoses.
Dermagnostix announces PsorX-LabDisk as their first CE-IVD
Dermagnostix announces PsorX LabDisks are now CE-IVD test kits in Germany. PsorX is a first in-class molecular test to support differential diagnosis of psoriasis and eczema or atopic dermatitis. PsorX two-gene classifier accurately and efficiently distinguishes psoriasis from eczema, even in cases where conventional diagnostic methods have failed.
Dermagnostix achieves EN ISO 13485:2016 certification
Dermagnostix proudly announces completion of ISO certification. Dermagnostix passed Stage 1 of ISO certification in May, 2022 and was recommended for Stage 2. In December we fully qualified our products for market entry and passed stage 2 to complete the certification of Dermagnostix and implementation of PsorX in a fully automated miniature laboratory for minimally
Dermagnostix announces commercial pilot of PsorX-LabDisk
Dermagnostix announces the commercial pilot of PsorX LabDisks as CE-IVD test kits in Germany. PsorX is a first in-class molecular test for differential diagnosis of psoriasis and eczema or atopic dermatitis. PsorX two-gene classifier accurately and efficiently distinguishes psoriasis from all forms of eczema, even in cases where conventional diagnostic methods have failed.
PsorX- LabDisk announces CE-IVD mark for PsorX-LabDisk and LabDisk-Analyzer
Dermagnostix announces CE-IVD mark for PsorX LabDisk and LabDisk-Analyzer. CE-IVD mark for PsorX provides our customers with the knowledge and assurance that our point of need solution is developed with the highest standards for efficacy and safety. “The receipt of the CE-IVD mark is an important milestone for Dermagnostix as we move towards commercialization. It